Statement Of Cash Flows [Abstract]
| Concept |
2022-01-01 to 2022-12-31 |
2021-01-01 to 2021-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for finance income (cost) |
620,000
USD
|
2 369
USD
|
| Cash flows from (used in) operations before changes in working capital |
216 714
USD
|
178 796
USD
|
| Increase (decrease) in working capital |
6 455
USD
|
8 523
USD
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
1 769
USD
|
2 404
USD
|
| Adjustments for gains (losses) on change in fair value of derivatives |
1 558
USD
|
2 178
USD
|
| Adjustments for gain (loss) on disposals, property, plant and equipment |
162,000
USD
|
1 241
USD
|
| Income taxes paid, classified as operating activities |
44 964
USD
|
9 962
USD
|
| Cash flows from (used in) investing activities [abstract] | ||
| Dividends received from investments accounted for using equity method, classified as investing activities |
0
USD
|
0
USD
|
| Purchase of investment property |
0
USD
|
0
USD
|
| Purchase of biological assets |
29 429
USD
|
27 396
USD
|
| Cash flows from (used in) financing activities [abstract] | ||
| Dividends paid to equity holders of parent, classified as financing activities |
22 280
USD
|
4 443
USD
|
| Dividends paid to non-controlling interests, classified as financing activities |
1 720
USD
|
2 306
USD
|
| Proceeds from sale or issue of treasury shares |
109,000
USD
|
1 033
USD
|
| Proceeds from non-current borrowings |
755,000
USD
|
0
USD
|
| Repayments of non-current borrowings |
18 642
USD
|
18 078
USD
|
| Proceeds from current borrowings |
106,000
USD
|
0
USD
|
| Repayments of current borrowings |
7 154
USD
|
73 710
USD
|